Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Palbociclib | 0.031623 | uM | 3 | 1250.00 | 603.29 | 2011.00 | 1750.25 | 1.1490 | 1.1892 |
| BT-20 | Taxol | 1 | uM | 3 | 1250.00 | 603.29 | 578.00 | 1750.25 | 0.3302 | -0.0275 |
| BT-20 | Palbociclib | 3.1623 | uM | 3 | 1250.00 | 603.29 | 810.00 | 1750.25 | 0.4628 | 0.2114 |
| BT-20 | Omipalisib | 0.0033113 | uM | 3 | 1250.00 | 603.29 | 1838.00 | 1750.25 | 1.0501 | 1.0647 |
| BT-20 | Methotrexate | 0.1 | uM | 3 | 1250.00 | 603.29 | 1880.00 | 1750.25 | 1.0741 | 1.0953 |
| BT-20 | Omipalisib | 10 | uM | 3 | 1250.00 | 603.29 | 197.00 | 1750.25 | 0.1126 | -0.5173 |
| BT-20 | Methotrexate | 1 | uM | 3 | 1250.00 | 603.29 | 1880.00 | 1750.25 | 1.0741 | 1.0953 |
| BT-20 | Methotrexate | 0.0033113 | uM | 3 | 1250.00 | 603.29 | 1970.00 | 1750.25 | 1.1256 | 1.1600 |
| BT-20 | 0 | uM | 3 | 1250.00 | 603.29 | 1631.00 | 1750.25 | 0.9319 | 0.9102 | |
| BT-20 | 0 | uM | 3 | 1250.00 | 603.29 | 1483.00 | 1750.25 | 0.8473 | 0.7956 | |
| BT-20 | 0 | uM | 3 | 1250.00 | 603.29 | 1332.00 | 1750.25 | 0.7610 | 0.6744 | |
| BT-20 | 0 | uM | 3 | 1250.00 | 603.29 | 1428.00 | 1750.25 | 0.8159 | 0.7519 | |
| BT-20 | Taxol | 0.01 | uM | 3 | 1250.00 | 603.29 | 630.00 | 1750.25 | 0.3600 | 0.0286 |
| BT-20 | Taxol | 0.1 | uM | 3 | 1250.00 | 603.29 | 593.00 | 1750.25 | 0.3388 | -0.0111 |
| BT-20 | Methotrexate | 0.31623 | uM | 3 | 1250.00 | 603.29 | 1764.00 | 1750.25 | 1.0079 | 1.0102 |
| BT-20 | Taxol | 0.00016596 | uM | 3 | 1250.00 | 603.29 | 2113.00 | 1750.25 | 1.2073 | 1.2608 |
| BT-20 | Palbociclib | 19.9526 | uM | 3 | 1250.00 | 603.29 | 819.00 | 1750.25 | 0.4679 | 0.2201 |
| BT-20 | Omipalisib | 0.1 | uM | 3 | 1250.00 | 603.29 | 540.00 | 1750.25 | 0.3085 | -0.0696 |
| BT-20 | 0 | uM | 3 | 1250.00 | 603.29 | 2271.00 | 1750.25 | 1.2975 | 1.3694 | |
| BT-20 | Palbociclib | 1 | uM | 3 | 1250.00 | 603.29 | 822.00 | 1750.25 | 0.4697 | 0.2230 |
| BT-20 | Omipalisib | 3.1623 | uM | 3 | 1250.00 | 603.29 | 314.00 | 1750.25 | 0.1794 | -0.3462 |
| BT-20 | 0 | uM | 3 | 1250.00 | 603.29 | 2160.00 | 1750.25 | 1.2341 | 1.2934 | |
| BT-20 | Omipalisib | 1 | uM | 3 | 1250.00 | 603.29 | 450.00 | 1750.25 | 0.2571 | -0.1737 |
| BT-20 | Methotrexate | 0.0016596 | uM | 3 | 1250.00 | 603.29 | 2121.00 | 1750.25 | 1.2118 | 1.2664 |
| BT-20 | Palbociclib | 0.01 | uM | 3 | 1250.00 | 603.29 | 2091.00 | 1750.25 | 1.1947 | 1.2455 |